CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Haemonetics Fiscal Q2 2012 Earnings Report | CapyFin

Haemonetics

HAE · NYSE🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q4 2026 in 27d Q3 2026 Q2 2026 +31.77%Q1 2026 -26.83%Q4 2025 +5.87%Q3 2025 -11.58%Q2 2025 +11.85%Q1 2025 -10.14%Q4 2024 +2.80%Q3 2024 -3.77%Q2 2024 +2.36%Q1 2024 +2.01%Q4 2023 +7.64%Q3 2023 -5.45%Q2 2023 +4.12%Q1 2023 +8.11%Q4 2022 +3.90%Q3 2022 +21.18%Q2 2022 -13.52%Q1 2022 +8.38%Q4 2021 -6.40%Q3 2021 +12.84%Q2 2021 -3.72%Q1 2021 -12.72%Q4 2020 -8.80%Q3 2020 +7.19%Q2 2020 +0.29%Q1 2020 +10.52%Q4 2019 +2.81%Q3 2019 -12.16%Q2 2019 +9.14%Q1 2019 +4.80%Q4 2018 +5.81%Q3 2018 +14.84%Q2 2018 +15.78%Q1 2018 +4.20%Q4 2017 -1.90%Q3 2017 -10.14%Q2 2017 +10.48%Q1 2017 +13.79%Q4 2016 -15.05%Q3 2016 +5.88%Q2 2016 -3.93%Q1 2016 +1.45%Q4 2015 -3.94%Q3 2015 +7.03%Q2 2015 -5.91%Q1 2015 -1.36%Q4 2014 -7.97%Q3 2014 -2.60%Q2 2014 +1.52%Q1 2014 +0.72%Q4 2013 -1.40%Q3 2013 -5.63%Q2 2013 +4.26%Q1 2013 -0.10%Q4 2012 +4.16%Q3 2012 -1.02%Q2 2012 +0.44%Q1 2012 +3.06%Q4 2009 +1.33%Q4 2011 +1.33%Q3 2010 -1.29%Q3 2011 -1.29%Q2 2011 +1.70%Q1 2010 -2.53%Q1 2011 -2.53%Q2 2010 -2.53%Q4 2010 -2.53%

Nov 03, 2011

•

Oct 01, 2011

Haemonetics Q2 2012 Earnings Report

Previous year: $167M

Previous year: $0.435

Previous year: $87.8M

Cash and Equivalents

Previous year: $115M

Previous year: $21.9M

Previous year: $738M

Haemonetics

Unlock previous datapoints

Haemonetics

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Haemonetics